You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Fusion Protein

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Latent Tuberculosis Infection Trial (Recombinant Mycobacterium tuberculosis fusion protein for injection, TB-PPD was injected)

Not yet recruiting
  • Latent Tuberculosis Infection
  • Recombinant Mycobacterium tuberculosis fusion protein for injection
  • TB-PPD was injected
  • (no location specified)
Feb 16, 2023

Latent Tuberculosis Infection Trial (Recombinant Mycobacterium Tuberculosis Fusion Protein, Purified Protein Derivative of

Not yet recruiting
  • Latent Tuberculosis Infection
  • Recombinant Mycobacterium Tuberculosis Fusion Protein
  • Purified Protein Derivative of Tuberculin
  • (no location specified)
Jun 8, 2023

Acute Gout Trial in Nanchang (rhTNFR-Fc, Triamcinolone Acetonide)

Not yet recruiting
  • Acute Gout
  • Nanchang, Jiangxi, China
    Department of Rheumatology and Clinical Immunology, Jiangxi Prov
Jun 28, 2023

Acute Myeloid Leukemia Trial in Los Angeles, San Francisco (Azacitidine, Tagraxofusp-erzs)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Los Angeles, California
  • +1 more
Jan 31, 2023

Advanced Solid Tumor, Refractory Non-Hodgkin Lymphoma Trial (HCB101)

Not yet recruiting
  • Advanced Solid Tumor
  • Refractory Non-Hodgkin Lymphoma
  • (no location specified)
May 28, 2023

Acute Myeloid Leukemia Trial in Baltimore (Dose Escalation -tagraxofusp-erzs, Dose Expansion at RP2D -tagraxofusp-erzs)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Dose Escalation -tagraxofusp-erzs
  • Dose Expansion at RP2D -tagraxofusp-erzs
  • Baltimore, Maryland
    The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Jan 27, 2023

Health Volunteer Trial in Beijing (Recombinant human CTLA-4-FC fusion protein for injection 1mg/kg, Recombinant human CTLA-4-FC

Recruiting
  • Health Volunteer
  • Recombinant human CTLA-4-FC fusion protein for injection 1mg/kg
  • +9 more
  • Beijing, China
    Peking University People's Hospital
Feb 15, 2022

COVID-19 Pandemic Trial in Zhuhai (Recombinant SARS-CoV-2 Fusion Protein Vaccine 10µg, Recombinant SARS-CoV-2 Fusion Protein

Active, not recruiting
  • COVID-19 Pandemic
  • Recombinant SARS-CoV-2 Fusion Protein Vaccine 10μg
  • +2 more
  • Zhuhai, Guangdong, China
    Zhuhai Peoples' Hospital Medical Group
Mar 12, 2022

Cancer, Tumor, Solid, Advanced Solid Tumor Trial in Brussels, Barcelona, Madrid (JK08)

Recruiting
  • Cancer
  • +6 more
  • Brussels, Belgium
  • +3 more
Jan 30, 2023

Severe Hemophilia A Trial in China (ADVATE, FRSW117)

Completed
  • Severe Hemophilia A
  • Guangzhou, Guangzhou, China
  • +3 more
Jun 27, 2022

Blastic Plasmacytoid Dendritic Cell Tumor Trial in Houston (Tagraxofusp-erzs)

Active, not recruiting
  • Blastic Plasmacytoid Dendritic Cell Neoplasm
  • Tagraxofusp-erzs
  • Houston, Texas
    M D Anderson Cancer Center
Apr 8, 2022

Severe Hemophilia A Trial in China (FRSW117)

Not yet recruiting
  • Severe Hemophilia A
  • Beijing, China
  • +27 more
Nov 16, 2023

COVID-19 Pandemic Trial in Malaysia, Pakistan (Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01), Blank Preparation of

Active, not recruiting
  • COVID-19 Pandemic
  • Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01)
  • Blank Preparation of Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01)
  • Kuching, Sarawak, Malaysia
  • +17 more
Aug 31, 2022

Natural Matrix Protein™ Fibers in Cervical and Lumbar Interbody

Not yet recruiting
  • Degenerative Disc Disease
  • +2 more
  • Natural Matrix Protein (NMP) Fibers
  • +2 more
  • Jasper, Alabama
    Southern Orthopedic Sports Medicine Associates
Aug 16, 2023

Hemophilia A Trial in China (ADVATE, FRSW107)

Recruiting
  • Hemophilia A
  • Beijing, Beijing, China
  • +5 more
Jun 27, 2022

NSCLC Stage IV, ALK Fusion Protein Expression Trial (Peptide vaccine)

Not yet recruiting
  • NSCLC Stage IV
  • ALK Fusion Protein Expression
  • Peptide vaccine
  • (no location specified)
Jul 21, 2023

COVID-19 Pandemic Trial in Zhuhai (Recombinant SARS-CoV-2 Fusion Protein Vaccine)

Active, not recruiting
  • COVID-19 Pandemic
  • Recombinant SARS-CoV-2 Fusion Protein Vaccine
  • Zhuhai, Guangdong, China
    The Fifth Peoples' Hospital of Zhuhai
Feb 15, 2022

Advanced Malignant Tumors Trial (AK130)

Not yet recruiting
  • Advanced Malignant Tumors
  • (no location specified)
Dec 7, 2022

COVID19 Trial in Guangzhou (Recombinant SARS-CoV-2 Fusion Protein Vaccine)

Completed
  • COVID19
  • Recombinant SARS-CoV-2 Fusion Protein Vaccine
  • Guangzhou, Guangdong, China
    Guangdong Provincial Center for Disease Control and Prevention
Feb 10, 2022

Cancer Fusion Hybrids and Desmoplasia

Recruiting
  • Fusion Protein Expression
  • Bone Marrow Cells
    • Miaoli, Taiwan
      National Institute of Cancer Research, National Health Research
    May 30, 2022

    Malignant Pleural Effusions Trial in Australia (SCB-313)

    Completed
    • Malignant Pleural Effusions
    • Liverpool, New South Wales, Australia
    • +3 more
    Feb 1, 2022

    COVID-19 Pandemic Trial in Indonesia, Philippines, Russian Federation (Recombinant SARS-CoV-2 fusion protein vaccine (V-01),

    Active, not recruiting
    • COVID-19 Pandemic
    • Recombinant SARS-CoV-2 fusion protein vaccine (V-01)
    • Blank Preparation of Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01)
    • Padang, Indonesia
    • +24 more
    Aug 31, 2022

    Healthy Trial in Shanghai (SI-F019)

    Completed
    • Healthy
    • Shanghai, Shanghai, China
      Shanghai Public Health Clinical Center Ethics Committee Approval
    Dec 11, 2022

    Chronic Myelomonocytic Leukemia, Chronic Myelomonocytic Leukemia-1, Chronic Myelomonocytic Leukemia-2 Trial in Houston

    Recruiting
    • Chronic Myelomonocytic Leukemia
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Mar 4, 2022

    Osteoporosis, Spinal Fusion Trial (RhBMP-2)

    Not yet recruiting
    • Osteoporosis
    • Spinal Fusion
    • (no location specified)
    Jun 20, 2023